drugset / Trial / NCT00148902

Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

NCT00148902

Phase 1 Completed 52 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a safety and tolerability study of GW572016 given with docetaxel (TAXOTERE).

Timeline

Start
2003-04-28
Primary completion
2006-01-21
Completion
2006-01-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Lapatinib Small molecule
Background Docetaxel Small molecule

Indications